Norfloxacin Export Market Intelligence: India's 207 Suppliers Shipping to 96 Countries — TransData Nexus 2026

Q: Who are the top norfloxacin exporters from India?

The top norfloxacin exporters from India are: 1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $1.2M (14.2% market share); 2. PINNACLE LIFE SCIENCE PRIVATE LIMITED — $552.4K (6.7% market share); 3. IPCA LABORATORIES LIMITED — $535.6K (6.5% market share); 4. MEDICAMEN BIOTECH LIMITED — $449.7K (5.4% market share); 5. ARBRO PHARMACEUTICALS PRIVATE LIMITED — $377.7K (4.6% market share). Together they account for 37.4% of India's total norfloxacin export value.

Q: What is the total export value of norfloxacin from India?

The total export value of norfloxacin from India is $8.3M USD, recorded across 1,394 shipment transactions from 207 active exporters to 96 destination countries. The average shipment value is $5.9K.

Q: Which countries import norfloxacin from India?

India exports norfloxacin to 96 countries worldwide. The top importing countries are: RUSSIA (15.4% share, $1.3M), ETHIOPIA (12.4% share, $1.0M), AFGHANISTAN (7.8% share, $640.7K), CONGO DR (6.2% share, $509.7K), MYANMAR (5.9% share, $487.7K). These five markets account for 47.6% of total export value.

Q: What is the HS code for norfloxacin exports from India?

The primary HS code for norfloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of norfloxacin exports from India?

The average unit price for norfloxacin exports from India is $6.87 USD per unit, with prices ranging from $0.01 to $644.01 depending on formulation, packaging, and order volume. The total market is valued at $8.3M across 1,394 shipments.

Q: Which ports handle norfloxacin exports from India?

The primary ports for norfloxacin exports from India are DELHI AIR CARGO ACC (INDEL4) (13.3% of shipments), SAHAR AIR CARGO ACC (INBOM4) (10.0% of shipments), SAHAR AIR (9.7% of shipments), DELHI AIR (8.1% of shipments), NHAVA SHEVA SEA (INNSA1) (7.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of norfloxacin?

India is one of the world's leading exporters of norfloxacin due to its large base of 207 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports norfloxacin to 96 countries, demonstrating 49% global market coverage.

Q: What certifications do Indian norfloxacin exporters need?

Indian norfloxacin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import norfloxacin from India?

There are 460 registered buyers importing norfloxacin from India, spread across 96 countries. The repeat buyer rate is 45.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top norfloxacin supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading norfloxacin exporter from India with a market share of 14.2% and total export value of $1.2M across 33 shipments. The top 5 suppliers together control 37.4% of total export value.

Suresh Sormare

Norfloxacin

India Pharmaceutical Trade Intelligence

$8.3M207 Suppliers96 CountriesHS 30049099

ExportsIndia → RUSSIA15.4%India → ETHIOPIA12.4%

ImportsCANADA → India$26 ITALY → India$11

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: AO RANBAXY

Norfloxacin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Norfloxacin to the World

Between 2022 and 2026, India exported $8.3M worth of norfloxacin across 1,394 verified shipments to 96 countries — covering 49% of world markets in the Advanced Antibiotics segment. The largest destination is RUSSIA (15.4%). SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 14.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Norfloxacin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Norfloxacin export data snapshot — $8.3M · 207 exporters · 96 countriesTransData Nexus · Indian Customs Data

Top Norfloxacin Exporters from India

207 active exporters · Ranked by export value

View all 207 →

Top Norfloxacin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$1.2M	33	4	14.2%
2	PINNACLE LIFE SCIENCE PRIVATE LIMITED

Top Countries Importing Norfloxacin from India

96 destination markets · Ranked by import value

All 96 countries →

Top Countries Importing Norfloxacin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	RUSSIA	$1.3M	15.4%
2	ETHIOPIA	$1.0M	12.4%
3	AFGHANISTAN	$640.7K	7.8%
4	CONGO DR	$509.7K	6.2%
5	MYANMAR	$487.7K	5.9%
6	CONGO	$437.8K	5.3%
7	TANZANIA	$428.3K	5.2%
8	ANGOLA	$368.5K	4.5%
9	FRANCE	$291.7K	3.5%
10	SOMALIA	$248.6K	3.0%

RUSSIA is India's largest norfloxacin export destination, absorbing 15.4% of total exports worth $1.3M. The top 5 importing countries — RUSSIA, ETHIOPIA, AFGHANISTAN, CONGO DR, MYANMAR — together account for 47.6% of India's total norfloxacin export value. The remaining 91 destination countries collectively receive the other 52.4%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Norfloxacin to India?

2 origin countries · Total import value: $37

India imports norfloxacin from 2 countries with a combined import value of $37. The largest supplier is CANADA ($26, 5 shipments), followed by ITALY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Norfloxacin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CANADA	$26	5	70.1%
2	ITALY	$11	1	29.9%

CANADA is the largest supplier of norfloxacin to India, accounting for 70.1% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Norfloxacin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for norfloxacin, indicating its established presence in the U.S. market. The most recent approval was granted in June 2025. Currently, there are no active FDA import alerts specifically targeting norfloxacin products from India, suggesting compliance with U.S. regulatory standards. Given that 207 Indian exporters are active in the norfloxacin market, this reflects a robust engagement with the U.S. pharmaceutical sector.

2EU & UK Regulatory Framework

In July 2008, the European Medicines Agency (EMA) recommended restricting the use of oral norfloxacin-containing medicines for treating complicated pyelonephritis due to insufficient evidence of efficacy. Consequently, this indication was removed from the marketing authorizations across EU member states. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA directives, enforcing similar restrictions. Manufacturers exporting to these regions must adhere to EU Good Manufacturing Practice (GMP) standards to ensure product quality and regulatory compliance.

3WHO Essential Medicines & Global Standards

Norfloxacin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. It is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality parameters for its production and use worldwide.

4India Regulatory Classification

In India, norfloxacin is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for its dispensation. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for norfloxacin formulations, with the latest revision in September 2025. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) to comply with export regulations.

5Patent & Exclusivity Status

The primary patents for norfloxacin have expired, leading to a competitive generic market. This has resulted in increased participation from multiple manufacturers, contributing to the 207 active Indian exporters and a repeat buyer rate of 45.9%.

6Recent Industry Developments

In October 2025, the NPPA revised the ceiling price for norfloxacin tablets, reducing it by 5% to enhance affordability. In December 2025, the CDSCO issued new guidelines for the bioequivalence studies of fluoroquinolones, including norfloxacin, to ensure consistent therapeutic efficacy. In February 2026, the WHO updated its Essential Medicines List, reaffirming the inclusion of norfloxacin for specific indications. In March 2026, the EMA initiated a review of fluoroquinolone antibiotics, including norfloxacin, to assess potential safety concerns related to long-term use. In April 2026, the DGFT streamlined the export NOC process for pharmaceuticals, reducing approval times by 20%, benefiting norfloxacin exporters.

These developments reflect a dynamic regulatory environment for norfloxacin, emphasizing the need for exporters to stay informed and compliant with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Norfloxacin

Retail & reference prices across 9 markets vs. India FOB export price of $6.87/unit

Global Price Benchmark for Norfloxacin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.58	USD	According to the FDA Orange Book, Norfloxacin is an approved generic drug in the U.S.
United Kingdom	Data not available	GBP	Norfloxacin is listed in the British National Formulary (BNF) as an approved antibiotic.
Germany	Data not available	EUR	Norfloxacin is approved by the European Medicines Agency (EMA) for use in Germany.
Australia	Data not available	AUD

Supply Chain Risk Assessment — Norfloxacin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Norfloxacin, a fluoroquinolone antibiotic, is primarily manufactured in India, which has established itself as a significant producer of Active Pharmaceutical Ingredients (APIs). However, the production of Norfloxacin APIs is heavily reliant on Key Starting Materials (KSMs) sourced from China. This dependency poses a substantial risk, as any disruption in the supply of these KSMs can directly impact the availability and cost of the final API. According to the U.S. Pharmacopeia, 58% of KSMs used for U.S.-approved APIs are sole-sourced from a single country, with 41% originating from China and 16% from India.

Recent geopolitical tensions have exacerbated this vulnerability. In February 2026, the closure of the Strait of Hormuz disrupted the supply of petrochemical feedstocks essential for pharmaceutical synthesis. This disruption has led to increased production costs and potential delays in API manufacturing. Such events underscore the fragility of the supply chain for Norfloxacin, given its reliance on specific geographic regions for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Norfloxacin account for 37.4% of total exports, with SUN PHARMACEUTICAL INDUSTRIES LIMITED leading at 14.2%. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact global supply. To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic production of critical APIs and reduce dependence on imports. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules used in antibiotics, marking a strategic move towards self-reliance.

Access Complete Norfloxacin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,394 transactions across 96 markets.

Request Demo View Pricing

Frequently Asked Questions — Norfloxacin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top norfloxacin exporters from India?

The leading norfloxacin exporters from India are SUN PHARMACEUTICAL INDUSTRIES LIMITED, PINNACLE LIFE SCIENCE PRIVATE LIMITED, IPCA LABORATORIES LIMITED, and 12 others. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 14.2% market share ($1.2M). The top 5 suppliers together control 37.4% of total export value.

What is the total export value of norfloxacin from India?

The total export value of norfloxacin from India is $8.3M, recorded across 1,394 shipments from 207 active exporters to 96 countries. The average shipment value is $5.9K.

Which countries import norfloxacin from India?

India exports norfloxacin to 96 countries. The top importing countries are RUSSIA (15.4%), ETHIOPIA (12.4%), AFGHANISTAN (7.8%), CONGO DR (6.2%), MYANMAR (5.9%), which together account for 47.6% of total export value.

What is the HS code for norfloxacin exports from India?

The primary HS code for norfloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Norfloxacin

Norfloxacin

Top Norfloxacin Exporters from India

Top Countries Importing Norfloxacin from India

Who Supplies Norfloxacin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Norfloxacin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Norfloxacin

Supply Chain Risk Assessment — Norfloxacin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Norfloxacin Trade Intelligence

Frequently Asked Questions — Norfloxacin Exports from India

Who are the top norfloxacin exporters from India?

What is the total export value of norfloxacin from India?

Which countries import norfloxacin from India?

What is the HS code for norfloxacin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of norfloxacin exports from India?

Which ports handle norfloxacin exports from India?

Why is India a leading exporter of norfloxacin?

What certifications do Indian norfloxacin exporters need?

How many buyers import norfloxacin from India?

What is the market share of the top norfloxacin exporter from India?

Analysis Methodology